...
首页> 外文期刊>Journal of Clinical Epidemiology >Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy.
【24h】

Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy.

机译:哪些不稳定型心绞痛或非Q波心肌梗死患者应立即进行心导管检查?用于预测谁将失败药物治疗的临床决策规则。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Unstable angina and non-Q-wave myocardial infarction (MI) are common and costly clinical events, but there is considerable uncertainty about optimal clinical management of these syndromes. We developed a prediction rule to help clinicians determine which patients with unstable angina or non-Q-wave MI are likely to "fail" medical therapy and ultimately require cardiac catheterization within 6 weeks of presentation. Subjects were 733 patients presenting with unstable angina or non-Q-wave MI enrolled in the TIMI IIIB trial and randomized to initial medical management. We developed a prediction rule based on logistic regression analysis of baseline data from history, physical examination, electrocardiogram, and blood studies. The outcome of interest was "failure" of medical therapy, defined as need for coronary catheterization within 42 days. Significant predictors of "failing" medical therapy included ST segment depression >or= .1 mV (odds ratio, OR, = 2.7, 95% confidence interval, CI, 1.8-4.1), accelerated angina in the prior 2 months (OR = 1.8, 95% CI 1.2-2.6), nitrate use in the prior week (OR = 1.6, 95% CI 1.1-2.2), exertional angina in the prior 2 months (OR = 1.6, 95% CI 1.1-2.2), and cardiac troponin I (cTnI) >or= 0.4 ng/mL (OR = 1.4, 95% CI 1.1-1.9). We used these variables to build a risk score by assigning point values based on these ORs. The risk score had a moderate ability to predict which patients would subsequently fail medical therapy and undergo cardiac catheterization (c = 0.682). Out of a total risk score of 13, failure of medical therapy occurred in 86% of patients who had a risk score >or= 8 (n = 111), 78% of patients who had a risk score >or= 6 (n = 240), and 72% of patients who had a risk score >or= 4 (n = 438). At scores of < 2 (n = 88), 40% of patients failed medical therapy. Although the management of unstable angina is in constant evolution, clinicians will always be faced with determining which patients should be managed most invasively. The simple prediction rule we present can be applied to patients with unstable angina or non-Q-wave MI at the time of presentation to predict which patients have a high probability of failing medical therapy. Such a rule may be useful for identifying patients who should be considered for early cardiac catheterization.
机译:不稳定型心绞痛和非Q波心肌梗塞(MI)是常见且代价高昂的临床事件,但对这些综合征的最佳临床治疗存在很大的不确定性。我们制定了预测规则,以帮助临床医生确定哪些不稳定型心绞痛或非Q波心梗患者可能“失败”药物治疗并最终需要在就诊后6周内进行心脏导管插入术。纳入TIMI IIIB试验的733名患有不稳定型心绞痛或非Q波MI的患者,并随机分配至初始医疗管理。我们基于对来自历史,体格检查,心电图和血液研究的基线数据进行逻辑回归分析,制定了预测规则。感兴趣的结果是药物治疗的“失败”,定义为在42天内需要进行冠状动脉导管插入术。 “失败”药物治疗的重要预测指标包括ST段压低>或= .1 mV(几率,OR,= 2.7,95%置信区间,CI,1.8-4.1),前2个月心绞痛加速(OR = 1.8) ,95%CI 1.2-2.6),前一周使用硝酸盐(OR = 1.6、95%CI 1.1-2.2),前两个月出现劳累性心绞痛(OR = 1.6、95%CI 1.1-2.2)和心脏肌钙蛋白I(cTnI)≥0.4 ng / mL(OR = 1.4,95%CI 1.1-1.9)。我们使用这些变量通过基于这些OR分配点值来建立风险评分。风险评分具有中等能力,可以预测哪些患者随后会因药物治疗失败而接受心脏导管检查(c = 0.682)。在13分的总危险评分中,有86%的危险评分>或= 8(n = 111)的患者发生了药物治疗失败,78%的危险评分> or = 6(n = 240),以及风险评分>或= 4(n = 438)的患者中有72%。得分<2(n = 88)时,有40%的患者药物治疗失败。尽管不稳定型心绞痛的治疗方法正在不断发展,但是临床医生将始终面临确定哪些患者应以最具侵入性的方式进行治疗的问题。我们提出的简单预测规则可以在出现时应用于不稳定型心绞痛或非Q波心梗的患者,以预测哪些患者极有可能无法接受药物治疗。这样的规则对于识别应考虑进行早期心脏导管插入术的患者可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号